MAPT and Alzheimer disease: In contrast, administration of ASOs at early stages did not affect plaque load.180 Responding to tau pathology, in the early stages of AD, TREM2 may suppress tau seeding, but later in AD, it may aggravate tau propagation.178,179,181,182